Gufic Biosciences (BOM:509079) Change In Inventory: ₹0 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:509079 Gufic Biosciences Ltd BOM:509079
71 GF Score
Price ₹445.40
GF Value ₹426.35
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Gufic Biosciences Change In Inventory?

Gufic Biosciences BOM:509079 +1.17% 71 Change In Inventory is ₹0 Mil as of Jun. 2026. GuruFocus rates BOM:509079 with a GF Score™ of 71/100 and a GF Value™ of ₹426.35 (Fairly Valued). The stock has 5 warning signs investors should review.

Gufic Biosciences's change in inventory for the quarter that ended in Jun. 2026 was ₹0 Mil. It means Gufic Biosciences's inventory stayed the same from Mar. 2026 to Jun. 2026 .

Gufic Biosciences's change in inventory for the fiscal year that ended in Mar. 2026 was ₹-1,076 Mil. It means Gufic Biosciences's inventory increased by ₹1,076 Mil from Mar. 2025 to Mar. 2026 .

Gufic Biosciences's Total Inventories for the quarter that ended in Jun. 2026 was ₹0 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Gufic Biosciences's Days Inventory for the quarter that ended in Jun. 2026 was 128.73.

Inventory Turnover measures how fast the company turns over its inventory within a year. Gufic Biosciences's Inventory Turnover for the quarter that ended in Jun. 2026 was 0.71.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Gufic Biosciences's Inventory-to-Revenue for the quarter that ended in Jun. 2026 was 0.62.

Gufic Biosciences  (BOM:509079) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Gufic Biosciences's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=1622.333/1149.997*365 / 4
=128.73

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Gufic Biosciences's Inventory Turnover for the quarter that ended in Jun. 2026 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=1149.997 / 1622.333
=0.71

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Gufic Biosciences's Inventory to Revenue for the quarter that ended in Jun. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=1622.333 / 2608.18
=0.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gufic Biosciences Change In Inventory Related Terms

Gufic Biosciences Change In Inventory Historical Data

* Premium members only.

The historical data trend for Gufic Biosciences's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gufic Biosciences Change In Inventory Chart

Gufic Biosciences Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Change In Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only -211.62 -678.91 -170.25 -163.87 -1,075.98

Gufic Biosciences Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:509079
71GF Score
Gufic Biosciences Ltd BOM:509079
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gufic Biosciences Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of ₹0 Mil mean?
Gufic Biosciences (BOM:509079) has a Change In Inventory of ₹0 Mil as of Jun. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Gufic Biosciences and its competitors.
Is Gufic Biosciences' Change In Inventory too high?
Gufic Biosciences' current Change In Inventory is ₹0 Mil. Overall, Gufic Biosciences has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Gufic Biosciences' Change In Inventory compare to ZTS?
Gufic Biosciences' Change In Inventory of ₹0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Drug Manufacturers company?
A good Change In Inventory depends on the Drug Manufacturers industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Gufic Biosciences and its competitors. Gufic Biosciences's current Change In Inventory is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gufic Biosciences stock overvalued right now?
Based on GuruFocus' analysis, Gufic Biosciences (BOM:509079) is currently considered Fairly Valued. The stock's GF Value™ is ₹426.35, compared to a current price of ₹445.40 — trading 4.5% above its estimated fair value. The current Change In Inventory is ₹0 Mil. Gufic Biosciences' overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Gufic Biosciences (BOM:509079), the current Change In Inventory is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Gufic Biosciences (BOM:509079) Overvalued in 2026?

Based on GuruFocus' analysis, Gufic Biosciences stock appears to be overvalued. The current stock price of ₹445.40 is trading 4.5% above its estimated GF Value™ of ₹426.35. GuruFocus considers Gufic Biosciences to be Fairly Valued.

Key valuation signals for BOM:509079:

  • Change In Inventory: ₹0 Mil
  • GF Value™: ₹426.35 vs. price of ₹445.40 (4.5% above fair value)
  • GF Score™: 71/100 with 5 warning signs

No single metric tells the full story. See the BOM:509079 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Gufic Biosciences Business Description

Other Exchanges GUFICBIO:India
Address SM House, 11 Sahakar Road, 1st to 4th Floor, Vile Parle (East), Mumbai, MH, IND, 400 057
Gufic Biosciences Ltd is engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals, and related services. Geographically, it derives a majority of revenue from India. Its product portfolio includes Criticare, Criticare Life, Ferticare, Spark, Herbal, and other products. The company's lyophilized product includes antibiotics, anti-fungal, cardiac, infertility, anti-viral, and a proton-pump inhibitor. It derives maximum revenue from India.
71GF Score

Get the complete analysis for BOM:509079

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹445.40
Price
₹426.35
GF Value